More doctors are refusing to meet with pharmaceutical reps, and the reps may have taken the hint. They're not scheduling appointments with those who aren't accessible. Cuts in the pharma industry have also lessened requests, but detailing via the Internet is also taking hold, letting reps meet with docs more spontaneously. Internist* and ACP Member Peter A. Lipson, MD, (aka PalMD) blogs that pharma influence is "a subtle influence which we are working hard to purge." (Wall Street Journal, White Coat Underground)
* Peter A. Lipson, ACP Member, was originally identified as a hospitalist in this post. He no longer does, as described in the comments below.